Tone mix
Week by week 52 weeks
Share of Biodesix, Inc. Common Stock's 115 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Sep 8, 2025 · tone -100Biodesix stock plummets on news of reverse stock split-140
- Week of Mar 23, 2026 · tone -100Baystreet.ca - Biodesix Wobbles on News About Biomarker-132
- Week of Jul 28, 2025 · tone +99Biodesix, APAPP Partner to Launch First CME-Accredited Education Program for Lung Cancer Biomarkers+74
- Week of Mar 9, 2026 · tone +100Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Rating of "Moderate Buy" by Brokerages+71
- Week of Mar 16, 2026 · tone +99Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis+70
- Week of May 25, 2026 · tone +99Canaccord Lifts PT on Biodesix (BDSX) on Raised Revenue Assumptions+66
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Biodesix, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 4 | +15 |
| Last 30 sessions | 8 | +32 |
| Last 90 sessions | 33 | +28 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
2 headlines, average tone +30: 1 positive, 1 neutral and 0 negative. Showing all 2.
- seekingalpha.com · 1 outletBiodesix expects $101M-$103M 2026 revenue while planning to exit 2026 with ~115 sales reps (NASDAQ:BDSX)Positive
- www.tickerreport.com · 1 outletBiodesix (NASDAQ:BDSX) Issues Earnings ResultsNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Biodesix expects $101M-$103M 2026 revenue while planning to exit 2026 with ~115 sales reps (NASDAQ:BDSX) | seekingalpha.com | 1 | Positive |
| Biodesix (NASDAQ:BDSX) Issues Earnings Results | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.manilatimes.net · 1 outletBiodesix to Participate in Upcoming Investor ConferencesNeutral
- www.themarketsdaily.com · 1 outletBiodesix (BDSX) Projected to Announce Quarterly Earnings on ThursdayNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Biodesix to Participate in Upcoming Investor Conferences | www.manilatimes.net | 1 | Neutral |
| Biodesix (BDSX) Projected to Announce Quarterly Earnings on Thursday | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletBiodesix to Report Third Quarter 2026 Financial Results on November 5, 2026Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026 | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
1 headline, average tone +98: 1 positive, 0 neutral and 0 negative. Showing all 1.
- econotimes.com · 1 outletBiodesix Targets 2028 Availability for AI-Assisted Lung Nodule Imaging TestPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Biodesix Targets 2028 Availability for AI-Assisted Lung Nodule Imaging Test | econotimes.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletBiodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging BiomarkersPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers | www.manilatimes.net | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Biodesix, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.